Meindert Danhof

19.4k total citations
496 papers, 15.3k citations indexed

About

Meindert Danhof is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Meindert Danhof has authored 496 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Molecular Biology, 116 papers in Cellular and Molecular Neuroscience and 109 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Meindert Danhof's work include Neuroscience and Neuropharmacology Research (86 papers), Receptor Mechanisms and Signaling (71 papers) and Epilepsy research and treatment (68 papers). Meindert Danhof is often cited by papers focused on Neuroscience and Neuropharmacology Research (86 papers), Receptor Mechanisms and Signaling (71 papers) and Epilepsy research and treatment (68 papers). Meindert Danhof collaborates with scholars based in Netherlands, United Kingdom and United States. Meindert Danhof's co-authors include Elizabeth C. M. de Lange, Catherijne A. J. Knibbe, D. D. Breimer, Oscar Della Pasqua, Bart A. Ploeger, Jaap W. Mandema, Piet H. van der Graaf, Ashraf Yassen, Albert Dahan and D.D. Breimer and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Nature Reviews Drug Discovery.

In The Last Decade

Meindert Danhof

493 papers receiving 14.8k citations

Peers

Countries citing papers authored by Meindert Danhof

Since Specialization

Citations

This map shows the geographic impact of Meindert Danhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meindert Danhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meindert Danhof more than expected).

Fields of papers citing papers by Meindert Danhof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meindert Danhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meindert Danhof. The network helps show where Meindert Danhof may publish in the future.

Co-authorship network of co-authors of Meindert Danhof

This figure shows the co-authorship network connecting the top 25 collaborators of Meindert Danhof. A scholar is included among the top collaborators of Meindert Danhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meindert Danhof. Meindert Danhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modeling of prolactin response following dopamine D₂receptor antagonists in rats: can it be translated to clinical dosing? 2017 ·Pharmacology Research & Perspectives ·Amit Taneja, An Vermeulen, Dymphy Huntjens, Meindert Danhof, Elizabeth C. M. de Lange, Johannes H. Proost	2
2	Prediction of methotrexate CNS distribution in different species – Influence of disease conditions 2014 ·European Journal of Pharmaceutical Sciences ·Joost Westerhout, Dirk‐Jan van den Berg, Robin Hartman, Meindert Danhof, Elizabeth C. M. de Lange	44
3	Evaluation of the Long-Term Durability and Glycemic Control of Fasting Plasma Glucose and Glycosylated Hemoglobin for Pioglitazone in Japanese Patients with Type 2 Diabetes 2014 ·Diabetes Technology & Therapeutics ·(unknown), Joost DeJongh, Kazuaki Enya, (unknown), Meindert Danhof, Kohei Kaku	7
4	The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults 2013 ·British Journal of Clinical Pharmacology ·Chenguang Wang, Karel Allegaert, Mariska Y. M. Peeters, Dick Tibboel, Meindert Danhof, Catherijne A. J. Knibbe	46
5	Developmental pharmacokinetics of propylene glycol in preterm and term neonates 2012 ·British Journal of Clinical Pharmacology ·Roosmarijn F. W. De Cock, Catherijne A. J. Knibbe, Aida Kulo, Jan de Hoon, René Verbesselt, Meindert Danhof, Karel Allegaert	27
6	Coping with time scales in disease systems analysis: application to bone remodeling 2011 ·Journal of Pharmacokinetics and Pharmacodynamics ·Stephan Schmidt, Teun M. Post, L. A. Peletier, M Boroujerdi, Meindert Danhof	28
7	The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women 2008 ·British Journal of Clinical Pharmacology ·Anouk E. Muller, P. Joep Dörr, Johan W. Mouton, Joost de Jongh, Paul M. Oostvogel, Eric A.P. Steegers, Rob A. Voskuyl, Meindert Danhof	15
8	Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research 2008 ·Trends in Pharmacological Sciences ·Meindert Danhof, Elizabeth C. M. de Lange, (unknown), Bart A. Ploeger, R.A. Voskuyl	206
9	Current issues relating to drug safety especially with regard to the use of biomarkers: A meeting report and progress update 2006 ·European Journal of Pharmaceutical Sciences ·Paul Rolan, Meindert Danhof, Donald Stanski, Carl C. Peck	7
10	A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus 2006 ·Journal of Pharmacokinetics and Pharmacodynamics ·Willem de Winter, Joost DeJongh, Teun M. Post, Bart A. Ploeger, Richard Urquhart, Ian K. Moules, (unknown), Meindert Danhof	112
11	Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery 2005 ·British Journal of Anaesthesia ·Sandra Prins, Mariska Y. M. Peeters, Robert Jan Houmes, Monique van Dijk, Catherijne A. J. Knibbe, Meindert Danhof, Dick Tibboel	14
12	The Comparative Pharmacodynamics of Remifentanil and Its Metabolite, GR90291, in a Rat Electroencephalographic Model 1999 ·Anesthesiology ·Eugène Cox, M.W.E. Langemeijer, J. M. Gubbens‐Stibbe, Keith T. Muir, Meindert Danhof	51
13	Selectivity of action of 8‐alkylamino analogues of N⁶‐cyclopentyladenosine in vivo: haemodynamic versus anti‐lipolytic responses in rats 1998 ·British Journal of Pharmacology ·E.A. van Schaick, (unknown), H. C. P. F. ROELEN, Adriaan P. IJzerman, Meindert Danhof	35
14	The Population Approach: Measuring and Managing Variability in Response, Concentration and Dose, Commission of the European Community, Luxembourg 1997 ·Research Explorer (The University of Manchester) ·(unknown), Mary M. Rowland, L. P. Balant, Meindert Danhof, Marianne Gex‐Fabry, (unknown), (unknown), France Mentré, P.L. Morselli, (unknown), (unknown), (unknown)	4
15	Influence of Chlorthalidone on the Pharmacokinetics and Pharmacodynamics of Org 10172 (Lomoparan®), A Low Molecular Weight Heparinoid, in Healthy Volunteers 1991 ·The Journal of Clinical Pharmacology ·Anthonius de Boer, (unknown), Meindert Danhof, D. D. Breimer	5
16	Interaction Study between Org 10172, a Low Molecular Weight Heparinoid, and Acetylsalicylic Acid in Healthy Male Volunteers 1991 ·Thrombosis and Haemostasis ·Angela G. E. M. de Boer, Meindert Danhof, Adam F. Cohen, (unknown), D. D. Breimer	7
17	Interaction of the Combined Medication with the New Low-Molecular-Weight Heparinoid Lomoparan® (Org 10172) and Acenocoumarol 1990 ·Pathophysiology of Haemostasis and Thrombosis ·(unknown), Anthonius de Boer, Meindert Danhof, (unknown), A.W. Broekmans, (unknown), (unknown), D.D. Breimer	2
18	Altered pharmacokinetic-pharmacodynamic relationship of heptabarbital in experimental renal failure in rats. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Jasper Dingemanse, Martine Polhuijs, Meindert Danhof	9
19	NEGLIGIBLE SUBLINGUAL ABSORPTION OF NIFEDIPINE 1987 ·The Lancet ·J. Van Harten, Meindert Danhof, (unknown), P. van Brummelen, (unknown)	75
20	Influence of the Genetically Controlled Deficiency in Debrisoquine Hydroxylation on Antipyrine Metabolite Formation 1981 ·Pharmacology ·Meindert Danhof, Jeffrey R. Idle, (unknown), (unknown), D.D. Breimer, (unknown)	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact